Hemostasis, LLC
Jeremy Nordling is currently working as a Production Specialist at Hemostasis, LLC since May 2021. Prior to this role, Jeremy worked at ACIST Medical Systems from September 2017 to May 2021, starting as a Manufacturing Assembler and progressing to Lead Service Technician. Jeremy also has experience in medical device rework at Minnetronix, Inc. and assembly work at Boston Scientific. With a background in business administration and management, Jeremy has held positions such as Operations Manager at Bigelow and Companies and Project Coordinator at Apex Companies, LLC.
This person is not in any teams
Hemostasis, LLC
Designs and manufactures advanced technology for hemostasis, specifically advanced blood clotting technology. NexStat Topical Hemostat Powder is intended for use under the care of a health care professional as a topical dressing for the temporary treatment of moderate to severely bleeding wounds such as surgical wounds (post-operative, donor sites, dermatological), cuts and lacerations and for the treatment of mild bleeding from topical ENT surgical wounds and nosebleeds. It is also indicated for control of bleeding from the skin at percutaneous needle access, vascular and percutaneous catheter access sites. NexFoam is a versatile sponge that can be used as a spacer, stent and hemostat. It dissolves naturally over 7-14 days or can be easily removed with gentle irrigation. Both NexStat and NexFoam are biocompatible and require no special storage conditions.